MIR6745

Across TCGA pan-cancer cohorts, MIR6745 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of MIR6745’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR6745 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6745 is over-expressed in tumor.

BLCA, HNSC, and BRCA are the cancer types where MIR6745 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6745 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.458	.005	5	view →
HNSC	Male	III,IV	+0.360	<.001	5	view →
BRCA	All	IV	+0.525	<.001	4	view →
LUSC	Male	All	+0.329	.001	4	view →
CHOL	All	All	+0.440	.047	1	view →
LUAD	All	All	+0.174	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

MIR6745–BLCA

Open the BLCA breakdown →